Two years after a rebuffed activist attack, Alex Denner finally gets his seat on Ironwood's board
Faced with an insurgency from the activist investor Alex Denner in 2018, Ironwood Pharmaceuticals mounted a vocal and ultimately successful campaign to keep the former Carl Icahn protégé off their board.
Now, two years later and with the company facing a restructuring and major questions about its board, Ironwood has issued a short and surprising press release: Alex Denner is joining the board.
“Ironwood has developed a strong relationship with Alex over these past few years, as Sarissa has become one of our largest shareholders,” Ironwood said in an emailed statement. “Alex knows Ironwood well, and the Board believes he brings to the company an important shareholder perspective as well as broad healthcare-industry knowledge and experience as a board director in overseeing the operations of healthcare companies.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.